Tumor BRCA Testing in High Grade Serous Carcinoma: Mutation Rates and Optimal Tissue Requirements.

Turashvili, Gulisa; Lazaro, Conxi; Ying, Shengjie; Charames, George; Wong, Andrew; Hamilton, Krista; Yee, Denise; Agro, Evangeline; Chang, Martin; Pollett, Aaron; Lerner-Ellis, Jordan

Turashvili, Gulisa; Lazaro, Conxi; Ying, Shengjie; Charames, George; Wong, Andrew; Hamilton, Krista; Yee, Denise; Agro, Evangeline; Chang, Martin; Pollett, Aaron; Lerner-Ellis, Jordan.

Afiliação

Turashvili G; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Lazaro C; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Ying S; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL, 08908 Barcelona, Spain.
Charames G; Cancer Network Consortium for Biomedical Research (CIBERONC), 08908 Barcelona, Spain.
Wong A; Women's College Research Institute, Women's College Hospital, Toronto, ON M5S 1B2, Canada.
Hamilton K; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Yee D; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Agro E; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Chang M; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Pollett A; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.
Lerner-Ellis J; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and University of Toronto, Toronto, ON M5G 1X5, Canada.